This website uses cookies to enhance the user experience.
||
A

ABBOTT DIAGNOSTICS TECHNOLOGIES AS981 363 019

Process industry
Limited company
Kjelsåsveien 161 0884 OSLO, Norge
Industry and manufacturing
/ Process industry
/ 21.200 Manufacture of pharmaceutical preparations

ABBOTT DIAGNOSTICS TECHNOLOGIES AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO
LR

Line Røed1974

Chairman of the board
OA

Oddvar Arne Vanberg1961

Years since formation
26 years
since Dec 13, 1999
Type
Limited company
VAT registered
Yes
Number of employees
315

Ownership

Number of shares and share classes
1,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
1,985,798,205
NOK
Annual total result 2024
382,415,581
NOK
Total equity 2024
822,305,573
NOK
Last update: Aug 12, 2025

Management

Management / administration

NameRoleShares
LR

Line Røed

1974

Managing Director/CEO-

Board

NameRoleShares
OA

Oddvar Arne Vanberg

1961

Chairman-
LR

Line Røed

1974

Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
Last update: Mar 13, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
A
AXIS-SHIELD AS
Ordinary shares
1,000
100 %
Last update: Jun 2, 2025

Group structure

  • AXIS-SHIELD AS
    Total operating income 2023: NOK 13,492,936
    Operating profit 2023: NOK 6,996,530
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,985,798,205
1,380,147,873
1,050,798,220
1,134,159,318
Annual Total Result
382,415,581
62,281,330
114,433,430
3,342,489,489
Total assets
1,357,262,250
1,596,122,563
3,099,622,158
4,993,690,645
Total liabilities
534,956,677
331,232,567
736,103,738
4,544,605,656
Total equity
822,305,573
1,264,889,996
2,363,518,420
449,084,989

P&L

Year2024202320222021
Total operating income
1,985,798,205
1,380,147,873
1,050,798,220
1,134,159,318
Total operating costs
1,550,420,854
1,386,652,004
963,575,550
825,878,765
Operating result
435,377,351
-6,504,131
87,222,670
308,280,553
Financial income/costs
54,526,530
85,266,161
58,435,644
4,986,528
Profit before tax
489,903,881
78,762,030
145,658,314
313,267,081
Total tax & extraordinary income/cost
107,488,300
16,480,700
31,224,884
-3,029,222,408
Annual Total Result
382,415,581
62,281,330
114,433,430
3,342,489,489

Balance overview

Year2024202320222021
Total fixed assets
778,147,158
1,109,060,073
2,691,895,495
4,241,991,061
Total current assets
579,115,092
487,062,490
407,726,663
751,699,584
Total assets
1,357,262,250
1,596,122,563
3,099,622,158
4,993,690,645
Short term debt
534,956,677
331,232,567
421,215,436
4,147,587,358
Long term debt
0
0
314,888,302
397,018,298
Total liabilities
534,956,677
331,232,567
736,103,738
4,544,605,656
Contributed capital
439,889,995
1,202,608,665
1,842,095,088
42,095,088
Retained earnings
382,415,578
62,281,331
521,423,332
406,989,901
Total equity
822,305,573
1,264,889,996
2,363,518,420
449,084,989
Total equity and liabilities
1,357,262,250
1,596,122,563
3,099,622,158
4,993,690,645

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations